Evaluation of Cisplatin and Cyclosporin A in Recurrent Platinum-Resistant Ovarian Cancer: A Phase II Study of the Gynecologic Oncology Group

Gynecologic Oncology ◽

10.1006/gyno.1997.4887 ◽

1998 ◽

Vol 68 (1) ◽

pp. 45-46 ◽

Author(s):

Alberto Manetta ◽

John A. Blessing ◽

Jean A. Hurteau

Keyword(s):

Ovarian Cancer ◽

Cyclosporin A ◽

Phase Ii ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Platinum Resistant

Download Full-text

A phase II study of neoadjuvant chemotherapy plus durvalumab and tremelimumab in advanced-stage ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 3046), TRU-D

Journal of Gynecologic Oncology ◽

10.3802/jgo.2019.30.e112 ◽

2019 ◽

Vol 30 (6) ◽

Author(s):

Jung-Yun Lee ◽

Jae Weon Kim ◽

Myong Cheol Lim ◽

Sunghoon Kim ◽

Hee Seung Kim ◽

...

Keyword(s):

Ovarian Cancer ◽

Neoadjuvant Chemotherapy ◽

Phase Ii ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Advanced Stage ◽

Oncology Group ◽

Oncology Group Study

Download Full-text

A Phase II Study of Fazarabine in Patients with Advanced Ovarian Cancer A Gynecologic Oncology Group Study

American Journal of Clinical Oncology ◽

10.1097/00000421-199504000-00012 ◽

1995 ◽

Vol 18 (2) ◽

pp. 156-157 ◽

Author(s):

Alberto Manetta ◽

John A. Blessing ◽

Katherine Y. Look

Keyword(s):

Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Advanced Ovarian Cancer ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Oncology Group Study

Download Full-text

A Gynecologic Oncology Group Phase II Study of Amonafide (NSC 308847) in Epithelial Ovarian Cancer

American Journal of Clinical Oncology ◽

10.1097/00000421-199312000-00015 ◽

1993 ◽

Vol 16 (6) ◽

pp. 529-531 ◽

Author(s):

Robert F. Asbury ◽

John A. Blessing ◽

Katherine Y. Look ◽

Daniel Clarke-Pearson ◽

Howard D. Homesley

Keyword(s):

Ovarian Cancer ◽

Epithelial Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Download Full-text

Tomudex (ZD1694, NSC 639186) in platinum-pretreated recurrent epithelial ovarian cancer: a phase II study by the Gynecologic Oncology Group

Cancer Chemotherapy and Pharmacology ◽

10.1007/s002800050786 ◽

1998 ◽

Vol 42 (1) ◽

pp. 68-70 ◽

Author(s):

Franco M. Muggia ◽

John A. Blessing ◽

Howard D. Homesley ◽

Joel Sorosky

Keyword(s):

Ovarian Cancer ◽

Epithelial Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Download Full-text

Altretamine (Hexamethylmelamine) in Platinum-Resistant and Platinum-Refractory Ovarian Cancer: A Gynecologic Oncology Group Phase II Trial

Gynecologic Oncology ◽

10.1006/gyno.1998.5016 ◽

1998 ◽

Vol 69 (3) ◽

pp. 226-229 ◽

Author(s):

Maurie Markman ◽

John A. Blessing ◽

David Moore ◽

Harrison Ball ◽

Samuel S. Lentz

Keyword(s):

Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Platinum Resistant ◽

Platinum Refractory

Download Full-text

A PHASE II STUDY WITH ADDITIONAL INTRAPERITONEAL CISPLATIN/ETOPOSIDE TO FIRST-LINE CHEMOTHERAPY FOR ADVANCED OVARIAN CANCER IN DEVELOPING COUNTRY: A SHANGHAI GYNECOLOGIC ONCOLOGY GROUP AICE TRIAL

10.26226/morressier.57baab48d462b80290b4bff4 ◽

2016 ◽

Author(s):

Rong Jiang

Keyword(s):

Ovarian Cancer ◽

Developing Country ◽

Phase Ii ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Advanced Ovarian Cancer ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Line Chemotherapy

Download Full-text

Cisplatin plus gemcitabine in previously treated squamous cell carcinoma of the cervix: A phase II study of the Gynecologic Oncology Group

Yearbook of Obstetrics Gynecology and Women s Health ◽

10.1016/s1090-798x(08)70269-8 ◽

2007 ◽

Vol 2007 ◽

pp. 386-387

Author(s):

B.J. Monk

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Previously Treated

Download Full-text

Phase II Evaluation of Pemetrexed in the Treatment of Recurrent or Persistent Platinum-Resistant Ovarian or Primary Peritoneal Carcinoma: A Study of the Gynecologic Oncology Group

Yearbook of Oncology ◽

10.1016/s1040-1741(09)79452-7 ◽

2009 ◽

Vol 2009 ◽

pp. 43-44

Author(s):

J.T. Thigpen

Keyword(s):

Phase Ii ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Peritoneal Carcinoma ◽

Primary Peritoneal Carcinoma ◽

Platinum Resistant

Download Full-text

A Gynecologic Oncology Group Phase II Study of Amonafide (NSC #308847) in Squamous Cell Carcinoma of the Cervix

American Journal of Clinical Oncology ◽

10.1097/00000421-199404000-00007 ◽

1994 ◽

Vol 17 (2) ◽

pp. 125-128 ◽

Author(s):

Robert F. Asbury ◽

John A. Blessing ◽

John T. Soper

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Download Full-text

Phase II Study of Ifosfamide and Mesna in Nonsquamous Carcinoma of the Cervix: A Gynecologic Oncology Group Study

Gynecologic Oncology ◽

10.1006/gyno.1993.1084 ◽

1993 ◽

Vol 49 (1) ◽

pp. 48-50 ◽

Author(s):

Gregory P. Sutton ◽

John A. Blessing ◽

Philip J. DiSaia ◽

William P. McGuire

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Oncology Group Study

Download Full-text